Cara Therapeutics, Inc. (CARA)

Cara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37.9	51.78	63.74	13.45	31.68
Short-Term Investments	-	48.98	81.66	153.58	149.24
Cash & Short-Term Investments	37.9	100.76	145.4	167.04	180.93
Cash Growth	-62.38%	-30.70%	-12.95%	-7.68%	16.72%
Accounts Receivable	0.41	2.77	3.26	-	-
Other Receivables	4.09	1.25	1.19	1.15	2.06
Receivables	4.5	4.02	4.45	1.15	2.06
Inventory	0.9	2.82	2.38	2.58	-
Prepaid Expenses	0.53	8.15	16.27	2.52	12.08
Restricted Cash	-	0.41	0.41	-	-
Total Current Assets	43.83	116.16	168.91	173.29	195.07
Property, Plant & Equipment	-	8.19	1.98	3.6	5.12
Long-Term Investments	-	-	11.35	69.75	70.57
Other Long-Term Assets	-	1.5	-	0.41	0.41
Total Assets	43.83	125.84	182.24	247.06	271.16
Accounts Payable	1.43	11.58	9.6	5.63	4.89
Accrued Expenses	2.54	14.01	11.94	10.24	11.99
Current Portion of Leases	-	-	1.92	1.76	1.6
Total Current Liabilities	3.97	25.59	23.46	17.62	18.48
Long-Term Debt	44.45	37.08	-	-	-
Long-Term Leases	-	6.09	-	1.92	3.67
Total Liabilities	48.42	68.76	23.46	19.53	22.16
Common Stock	0.01	0.01	0.05	0.05	0.05
Additional Paid-In Capital	751.01	742.09	726.63	708.59	641.2
Retained Earnings	-755.61	-684.75	-566.23	-480.76	-392.32
Comprehensive Income & Other	-	-0.26	-1.67	-0.36	0.07
Shareholders' Equity	-4.59	57.09	158.78	227.52	249
Total Liabilities & Equity	43.83	125.84	182.24	247.06	271.16
Total Debt	44.45	43.17	1.92	3.67	5.28
Net Cash (Debt)	-6.55	57.59	154.83	233.12	246.22
Net Cash Growth	-	-62.80%	-33.58%	-5.32%	15.14%
Net Cash Per Share	-1.43	12.76	34.63	55.15	61.66
Filing Date Shares Outstanding	4.57	4.55	4.5	4.46	4.16
Total Common Shares Outstanding	4.57	4.54	4.48	4.46	4.16
Working Capital	39.86	90.57	145.45	155.67	176.58
Book Value Per Share	-1.00	12.57	35.42	51.05	59.91
Tangible Book Value	-4.59	57.09	158.78	227.52	249
Tangible Book Value Per Share	-1.00	12.57	35.42	51.05	59.91
Machinery	-	0.84	0.57	0.57	1.17
Leasehold Improvements	-	4.15	1.27	1.22	1.21

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q